Sumitovant Biopharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2019-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.sumitovant.com
Study of the Safety and Pharmacokinetics of KSP-1007 Alone and Coadministered With Meropenem in Healthy Subjects
- First Posted Date
- 2022-02-07
- Last Posted Date
- 2022-10-27
- Lead Sponsor
- Sumitovant Biopharma, Inc.
- Target Recruit Count
- 123
- Registration Number
- NCT05226923
- Locations
- 🇺🇸
PRA Health Sciences, Lenexa, Kansas, United States
© Copyright 2024. All Rights Reserved by MedPath